Announcements
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences Announces Third Quarter 2023 Financial Results
- IGM Biosciences to Present at Two Upcoming Investor Conferences
- IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
- IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
More ▼
Key statistics
As of last trade, IGM Biosciences Inc (1K0:MUN) traded at 7.10, 88.83% above the 52 week low of 3.76 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.10 |
---|---|
High | 7.10 |
Low | 7.10 |
Bid | 6.85 |
Offer | 7.05 |
Previous close | 7.70 |
Average volume | 1.78 |
---|---|
Shares outstanding | 58.79m |
Free float | 21.56m |
P/E (TTM) | -- |
Market cap | 435.61m USD |
EPS (TTM) | -4.81 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 07:03 BST.
More ▼